CATEGORIES

05.09.2017

05.09.2017 16:37

Modum.io raises $10 million in token sale in five hours

modum.io announces that its token sale has raised $10 million in only five hours of opening on Friday 1 September, successfully fundraising for its revolutionary product using Blockchain and IoT technology in the pharma supply chain. The MOD token sale will be used to bring modum.io’s innovative supply chain solution to the market.

05.09.2017 11:45

AMAL Therapeutics raises CHF 8.8 million in Series B round

AMAL Therapeutics (AMAL), the Swiss biotech developing novel, peptide-based therapeutic cancer vaccines, announces today that it has completed the first tranche of its Series B financing round, raising of Euros 8 million (CHF 8.8 million). AMAL will use the funds to progress its lead vaccine and further develop its proprietary therapeutic tumour vaccination technology platform called KISIMA.

05.09.2017 09:04

Wachstumsfinanzierung für Adello

Nach der ersten Finanzierung durch Swisscom Ventures in 2014 hat das Adtech-Unternehmen Adello eine weitere Wachstumsrunde abgeschlossen.

04.09.2017

04.09.2017 16:39

CREALOGIX acquires AI technology of Koemei

CREALOGIX, a fintech company and market leader in digital banking, has purchased the artificial intelligence (AI) technology of Koemei, a spin-off of the IDIAP Research Institute based in Martigny, Wallis. Koemei’s solution enables for automated conversion of audio and video content into text data for analytics and optimisation, thanks to machine learning technology. CREALOGIX will adapt the technology as of autumn 2017.

04.09.2017 14:16

Euronext expands to Switzerland

Swiss companies including Geneuro and Genkyotex went public recently at Euronext. Now Euronext launches a European Tech SME initiative, opening offices in four new countries – Germany, Italy, Spain and Switzerland –  and deploying teams on the ground to work collaboratively with local ecosystems.

04.09.2017 11:45

Virometix closes extension financing round

Virometix has raised CHF 1.2 million from new shareholders in an extension to its recent Series A financing round. The additional funds will be used to further speed up development of its vaccine candidates for RSV and cancer immunotherapy. Furthermore, the company announced the appointment of Harry Welten, as new independent member of its Board of Directors.

31.08.2017

31.08.2017 10:14

Cloud-Hoster Exoscale geht an Telekom Austria

A1 digital international GmbH, eine Tochter der Telekom Austria Group, hat kürzlich mehrheitlich den Schweizer Cloud Anbieter Exoscale erworben und dabei auch Anteile von Swisscom Ventures und der Anaroll Holding übernommen.

Show All

Events

02.10.2017 17:00 - 20:00

Seif Award ceremony 2017 Volkshaus Zurich, Stauffacherstrasse 60, 8004 Zürich

Show All

Trainings

04.10.2017 @EPFL; 17:15-21:00

Startup Acceleration Workshop No. 1 : The story of your startup EPFL, Route Cantonale 1015 Lausanne BC 01/02

Top viewed

Show All

Video

Tweets

Principal

Partners

Contributors